US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON

0.7135

+0.00600.85%

Volume:8.02K

Turnover:5.75K

Market Cap:29.13M

PE:-0.38

High:0.7185

Open:0.7185

Low:0.7135

Close:0.7075

52wk High:2.92

52wk Low:0.6400

Shares:40.83M

Float Shares:35.68M

Volume Ratio:3.95

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.8802

EPS(LYR):-1.5521

ROE:-62.25%

ROA:-23.02%

PB:0.34

PE(LYR):-0.46

Loading ...

Overview Company News Filings

Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease

Barinthus Biotherapeutics Is Maintained at Buy by HC Wainwright & Co.

Barinthus Biotherapeutics Q3 EPS $(0.36) Beats $(0.45) Estimate, Sales $14.969M, Same YoY

Press Release: Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments

Barinthus Biotherapeutics PLC expected to post a loss of 45 cents a share - Earnings Preview

Press Release: ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus Therapeutics

Press Release: Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases

Barinthus Biotherapeutics PLC reports results for the quarter ended June 30 - Earnings Summary

Barinthus Biotherapeutics Q2 EPS $(0.52) Misses $(0.33) Estimate

Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments

Barinthus Biotherapeutics PLC expected to post a loss of 33 cents a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BRNS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BRNS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BRNS\",,,,,undefined,":{"symbol":"BRNS","market":"US","secType":"STK","nameCN":"BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON","latestPrice":0.7135,"timestamp":1770735193876,"preClose":0.7075,"halted":0,"volume":8019,"delay":0,"changeRate":0.008480565371024743,"floatShares":35677165,"shares":40830353,"eps":-1.880153,"marketStatus":"Trading","change":0.006,"latestTime":"02-10 09:59:24 EST","open":0.7185,"high":0.7185,"low":0.7135,"amount":5747.3873028,"amplitude":0.007067,"askPrice":0.74,"askSize":3930,"bidPrice":0.7,"bidSize":1913,"shortable":3,"etf":0,"ttmEps":-1.880153,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770757200000},"marketStatusCode":2,"adr":0,"adrRate":1,"listingDate":1619755200000,"exchange":"NASDAQ","adjPreClose":0.7075,"preHourTrading":{"tag":"盘前","latestPrice":0.7135,"preClose":0.7075,"latestTime":"09:21 EST","volume":3698,"amount":2585.90578512,"timestamp":1770733287807,"change":0.006,"changeRate":0.008481,"amplitude":0.625442},"postHourTrading":{"tag":"盘后","latestPrice":0.7075,"preClose":0.7075,"latestTime":"16:04 EST","volume":4,"amount":2.7732,"timestamp":1770671067445,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":3.947225},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BRNS\",,,,,undefined,":{"symbol":"BRNS","floatShares":35677165,"roa":"-23.02%","roe":"-62.25%","lyrEps":-1.55214,"volumeRatio":3.947225,"shares":40830353,"dividePrice":0,"high":0.7185,"amplitude":0.007067,"preClose":0.7075,"low":0.7135,"week52Low":0.64,"pbRate":"0.34","week52High":2.92,"institutionHeld":0,"latestPrice":0.7135,"committee":-0.345199,"eps":-1.880153,"divideRate":0,"volume":8019,"delay":0,"ttmEps":-1.880153,"open":0.7185,"prevYearClose":0.7001,"prevWeekClose":0.705,"prevMonthClose":0.73,"prevQuarterClose":0.7001,"fiveDayClose":0.745,"twentyDayClose":0.76,"sixtyDayClose":0.8091},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BRNS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-07","symbol":"BRNS","fiscalQuarterEnding":"2025/09","expectedEps":-0.45,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"pre","actualEps":-0.36},{"market":"US","date":"2025-08-07","symbol":"BRNS","fiscalQuarterEnding":"2025/06","expectedEps":-0.29,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.52},{"market":"US","date":"2025-05-07","symbol":"BRNS","fiscalQuarterEnding":"2025/03","expectedEps":-0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"pre","actualEps":-0.49},{"market":"US","date":"2025-03-20","symbol":"BRNS","fiscalQuarterEnding":"2024/12","expectedEps":-0.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"pre","actualEps":-0.51},{"market":"US","date":"2024-11-06","symbol":"BRNS","fiscalQuarterEnding":"2024/09","expectedEps":-0.45,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"pre","actualEps":-0.21}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BRNS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BRNS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1701493200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BRNS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BRNS","date":"2026-02-06","current":-0.376299,"percent":0.918519,"low":-2.280697,"twenty":-1.271197,"median":-0.757769,"eighty":-0.575164,"high":-0.364782,"avg":-0.870936,"sd":0.376178,"marketCap":30320620},"quantilePoints":[{"date":"2023-11-10","current":-2.280697,"twenty":-2.227364,"median":-2.147364,"eighty":-2.067364,"marketCap":125276430},{"date":"2023-11-17","current":-1.472853,"twenty":-1.912639,"median":-1.482838,"eighty":-1.444894,"marketCap":113767552},{"date":"2023-11-22","current":-1.35802,"twenty":-1.608463,"median":-1.465364,"eighty":-1.380987,"marketCap":104897539},{"date":"2023-12-01","current":-1.425372,"twenty":-1.531387,"median":-1.472853,"eighty":-1.406949,"marketCap":110099995},{"date":"2023-12-08","current":-1.545247,"twenty":-1.548243,"median":-1.492824,"eighty":-1.422886,"marketCap":119359516},{"date":"2023-12-15","current":-1.502809,"twenty":-1.545746,"median":-1.507071,"eighty":-1.435398,"marketCap":116081468},{"date":"2023-12-22","current":-1.667569,"twenty":-1.629624,"median":-1.518886,"eighty":-1.45388,"marketCap":128808008},{"date":"2023-12-29","current":-1.818598,"twenty":-1.661578,"median":-1.524178,"eighty":-1.463866,"marketCap":140474003},{"date":"2024-01-05","current":-1.822343,"twenty":-1.722489,"median":-1.530269,"eighty":-1.472853,"marketCap":140763242},{"date":"2024-01-12","current":-1.657583,"twenty":-1.757438,"median":-1.547743,"eighty":-1.472853,"marketCap":128036703},{"date":"2024-01-19","current":-1.647598,"twenty":-1.741461,"median":-1.572707,"eighty":-1.480841,"marketCap":127265397},{"date":"2024-01-26","current":-1.452882,"twenty":-1.725485,"median":-1.553984,"eighty":-1.480841,"marketCap":112224941},{"date":"2024-02-02","current":-1.352528,"twenty":-1.722489,"median":-1.532765,"eighty":-1.451873,"marketCap":104473321},{"date":"2024-02-09","current":-1.271197,"twenty":-1.706512,"median":-1.523479,"eighty":-1.406949,"marketCap":98191039},{"date":"2024-02-16","current":-1.238844,"twenty":-1.682547,"median":-1.517787,"eighty":-1.357411,"marketCap":95692009},{"date":"2024-02-23","current":-1.338049,"twenty":-1.677554,"median":-1.516789,"eighty":-1.341045,"marketCap":103354928},{"date":"2024-03-01","current":-1.41294,"twenty":-1.674558,"median":-1.50494,"eighty":-1.343042,"marketCap":109139719},{"date":"2024-03-08","current":-1.323071,"twenty":-1.669566,"median":-1.502809,"eighty":-1.343042,"marketCap":102197970},{"date":"2024-03-15","current":-1.253173,"twenty":-1.661577,"median":-1.472853,"eighty":-1.328064,"marketCap":96798832},{"date":"2024-03-22","current":-1.269731,"twenty":-1.654588,"median":-1.472853,"eighty":-1.301103,"marketCap":93130931},{"date":"2024-03-28","current":-1.236403,"twenty":-1.650594,"median":-1.452882,"eighty":-1.295112,"marketCap":90686423},{"date":"2024-04-05","current":-1.947467,"twenty":-1.650594,"median":-1.45036,"eighty":-1.291729,"marketCap":142840848},{"date":"2024-04-12","current":-1.767048,"twenty":-1.675557,"median":-1.472853,"eighty":-1.295112,"marketCap":129607635},{"date":"2024-04-19","current":-1.438048,"twenty":-1.670564,"median":-1.455378,"eighty":-1.298107,"marketCap":105476484},{"date":"2024-04-26","current":-1.288883,"twenty":-1.667031,"median":-1.438048,"eighty":-1.298107,"marketCap":94535731},{"date":"2024-05-03","current":-1.138233,"twenty":-1.662768,"median":-1.419156,"eighty":-1.291729,"marketCap":83485999},{"date":"2024-05-10","current":-1.247016,"twenty":-1.655586,"median":-1.407947,"eighty":-1.280564,"marketCap":91464848},{"date":"2024-05-17","current":-1.338523,"twenty":-1.650594,"median":-1.395374,"eighty":-1.278423,"marketCap":94574653},{"date":"2024-05-24","current":-1.248513,"twenty":-1.643604,"median":-1.379677,"eighty":-1.275322,"marketCap":88214937},{"date":"2024-05-31","current":-1.104879,"twenty":-1.635615,"median":-1.37437,"eighty":-1.270728,"marketCap":78066316},{"date":"2024-06-07","current":-1.046873,"twenty":-1.621636,"median":-1.366121,"eighty":-1.261117,"marketCap":73967834},{"date":"2024-06-14","current":-1.055159,"twenty":-1.597671,"median":-1.356497,"eighty":-1.253173,"marketCap":74553331},{"date":"2024-06-21","current":-0.690549,"twenty":-1.5777,"median":-1.352836,"eighty":-1.245382,"marketCap":48791447},{"date":"2024-06-28","current":-0.765129,"twenty":-1.570211,"median":-1.350281,"eighty":-1.236891,"marketCap":54060923},{"date":"2024-07-05","current":-0.789988,"twenty":-1.560225,"median":-1.343042,"eighty":-1.220891,"marketCap":55817415},{"date":"2024-07-12","current":-0.812086,"twenty":-1.547743,"median":-1.338523,"eighty":-1.203246,"marketCap":57378742},{"date":"2024-07-15","current":-0.834183,"twenty":-1.547244,"median":-1.338286,"eighty":-1.19142,"marketCap":58940068},{"date":"2024-08-02","current":-0.841641,"twenty":-1.546745,"median":-1.338049,"eighty":-1.17902,"marketCap":59467016},{"date":"2024-08-09","current":-0.844428,"twenty":-1.544819,"median":-1.331919,"eighty":-1.144779,"marketCap":53861854},{"date":"2024-08-16","current":-0.803496,"twenty":-1.539612,"median":-1.328064,"eighty":-1.092435,"marketCap":51250963},{"date":"2024-08-23","current":-0.772414,"twenty":-1.530768,"median":-1.322286,"eighty":-1.051845,"marketCap":49268402},{"date":"2024-08-30","current":-0.790952,"twenty":-1.527773,"median":-1.3031,"eighty":-1.045215,"marketCap":50450844},{"date":"2024-09-06","current":-0.760055,"twenty":-1.527054,"median":-1.298107,"eighty":-0.902686,"marketCap":48480108},{"date":"2024-09-13","current":-0.790952,"twenty":-1.523898,"median":-1.293812,"eighty":-0.829258,"marketCap":50450844},{"date":"2024-09-20","current":-0.756965,"twenty":-1.522221,"median":-1.290805,"eighty":-0.813197,"marketCap":48283034},{"date":"2024-09-27","current":-0.741517,"twenty":-1.519545,"median":-1.287184,"eighty":-0.79711,"marketCap":47297666},{"date":"2024-10-04","current":-0.766234,"twenty":-1.517727,"median":-1.278854,"eighty":-0.791312,"marketCap":48874255},{"date":"2024-10-11","current":-0.735276,"twenty":-1.517348,"median":-1.275766,"eighty":-0.790181,"marketCap":46899577},{"date":"2024-10-18","current":-0.741517,"twenty":-1.51599,"median":-1.271197,"eighty":-0.788177,"marketCap":47297666},{"date":"2024-10-25","current":-0.883641,"twenty":-1.511649,"median":-1.26959,"eighty":-0.788177,"marketCap":56363052},{"date":"2024-10-31","current":-0.883641,"twenty":-1.507071,"median":-1.261798,"eighty":-0.789436,"marketCap":56363052},{"date":"2024-11-08","current":-1.00297,"twenty":-1.502809,"median":-1.253173,"eighty":-0.789988,"marketCap":57998763},{"date":"2024-11-15","current":-0.960023,"twenty":-1.502809,"median":-1.24843,"eighty":-0.789988,"marketCap":55515269},{"date":"2024-11-22","current":-0.687502,"twenty":-1.482838,"median":-1.238844,"eighty":-0.784772,"marketCap":39756173},{"date":"2024-11-29","current":-0.685791,"twenty":-1.47485,"median":-1.235499,"eighty":-0.783536,"marketCap":39657211},{"date":"2024-12-06","current":-0.646972,"twenty":-1.472853,"median":-1.217885,"eighty":-0.773215,"marketCap":37412464},{"date":"2024-12-13","current":-0.570449,"twenty":-1.472853,"median":-1.204564,"eighty":-0.772414,"marketCap":32987333},{"date":"2024-12-20","current":-0.709582,"twenty":-1.472853,"median":-1.180594,"eighty":-0.767891,"marketCap":41033025},{"date":"2024-12-27","current":-0.737409,"twenty":-1.463866,"median":-1.162113,"eighty":-0.767891,"marketCap":42642163},{"date":"2025-01-03","current":-0.86263,"twenty":-1.455877,"median":-1.146416,"eighty":-0.766897,"marketCap":49883285},{"date":"2025-01-10","current":-0.793063,"twenty":-1.451873,"median":-1.104879,"eighty":-0.767891,"marketCap":45860439},{"date":"2025-01-17","current":-0.702626,"twenty":-1.445881,"median":-1.087822,"eighty":-0.76515,"marketCap":40630740},{"date":"2025-01-24","current":-0.751323,"twenty":-1.438048,"median":-1.055159,"eighty":-0.760055,"marketCap":43446732},{"date":"2025-01-31","current":-0.695669,"twenty":-1.437904,"median":-1.049635,"eighty":-0.751323,"marketCap":40228456},{"date":"2025-02-07","current":-0.695669,"twenty":-1.425372,"median":-1.046873,"eighty":-0.741517,"marketCap":40228456},{"date":"2025-02-14","current":-0.719983,"twenty":-1.41294,"median":-1.010409,"eighty":-0.741517,"marketCap":41634440},{"date":"2025-02-21","current":-0.733931,"twenty":-1.41294,"median":-0.988453,"eighty":-0.741517,"marketCap":42441021},{"date":"2025-02-28","current":-0.674799,"twenty":-1.408946,"median":-0.960023,"eighty":-0.737409,"marketCap":39021602},{"date":"2025-03-07","current":-0.709513,"twenty":-1.403161,"median":-0.92717,"eighty":-0.735338,"marketCap":41029002},{"date":"2025-03-14","current":-0.737409,"twenty":-1.400759,"median":-0.908358,"eighty":-0.735007,"marketCap":42642163},{"date":"2025-03-21","current":-0.665373,"twenty":-1.392324,"median":-0.894425,"eighty":-0.729208,"marketCap":40637009},{"date":"2025-03-28","current":-0.693525,"twenty":-1.384445,"median":-0.883641,"eighty":-0.723496,"marketCap":42356364},{"date":"2025-04-04","current":-0.50198,"twenty":-1.380338,"median":-0.866957,"eighty":-0.719294,"marketCap":30657940},{"date":"2025-04-11","current":-0.452443,"twenty":-1.378328,"median":-0.844428,"eighty":-0.715148,"marketCap":27632485},{"date":"2025-04-17","current":-0.465653,"twenty":-1.375818,"median":-0.840368,"eighty":-0.709554,"marketCap":28439273},{"date":"2025-04-25","current":-0.538968,"twenty":-1.373547,"median":-0.828027,"eighty":-0.702626,"marketCap":32916946},{"date":"2025-05-02","current":-0.719945,"twenty":-1.372998,"median":-0.823996,"eighty":-0.701628,"marketCap":43969940},{"date":"2025-05-09","current":-0.55655,"twenty":-1.364746,"median":-0.819794,"eighty":-0.695669,"marketCap":36305455},{"date":"2025-05-16","current":-0.537906,"twenty":-1.35851,"median":-0.812579,"eighty":-0.692991,"marketCap":35089222},{"date":"2025-05-23","current":-0.500895,"twenty":-1.356192,"median":-0.807791,"eighty":-0.687124,"marketCap":32674909},{"date":"2025-05-30","current":-0.680228,"twenty":-1.354242,"median":-0.797766,"eighty":-0.685478,"marketCap":44373334},{"date":"2025-06-06","current":-0.612205,"twenty":-1.352898,"median":-0.794041,"eighty":-0.680263,"marketCap":39936001},{"date":"2025-06-13","current":-0.565393,"twenty":-1.350731,"median":-0.792907,"eighty":-0.675893,"marketCap":36882308},{"date":"2025-06-20","current":-0.537999,"twenty":-1.347036,"median":-0.790952,"eighty":-0.674799,"marketCap":35095273},{"date":"2025-06-27","current":-0.570464,"twenty":-1.343042,"median":-0.789988,"eighty":-0.667846,"marketCap":37213091},{"date":"2025-07-03","current":-0.569598,"twenty":-1.343042,"median":-0.789988,"eighty":-0.667842,"marketCap":37156616},{"date":"2025-07-11","current":-0.655493,"twenty":-1.342532,"median":-0.786317,"eighty":-0.6605,"marketCap":42759758},{"date":"2025-07-18","current":-0.946136,"twenty":-1.338523,"median":-0.784772,"eighty":-0.659912,"marketCap":61719274},{"date":"2025-07-25","current":-1.079089,"twenty":-1.338049,"median":-0.789712,"eighty":-0.660434,"marketCap":70392244},{"date":"2025-08-01","current":-0.915216,"twenty":-1.338049,"median":-0.789988,"eighty":-0.6605,"marketCap":59702304},{"date":"2025-08-08","current":-0.850422,"twenty":-1.331919,"median":-0.790952,"eighty":-0.660886,"marketCap":59041432},{"date":"2025-08-15","current":-0.748313,"twenty":-1.331919,"median":-0.789988,"eighty":-0.661677,"marketCap":51952388},{"date":"2025-08-22","current":-0.695,"twenty":-1.328064,"median":-0.789712,"eighty":-0.661677,"marketCap":48251101},{"date":"2025-08-29","current":-0.691892,"twenty":-1.328064,"median":-0.785908,"eighty":-0.665373,"marketCap":48035294},{"date":"2025-09-05","current":-0.780043,"twenty":-1.326902,"median":-0.784772,"eighty":-0.664634,"marketCap":54155244},{"date":"2025-09-12","current":-0.662743,"twenty":-1.323779,"median":-0.782408,"eighty":-0.66253,"marketCap":46011598},{"date":"2025-09-19","current":-0.648081,"twenty":-1.321815,"median":-0.778593,"eighty":-0.66033,"marketCap":44993643},{"date":"2025-09-26","current":-0.709663,"twenty":-1.30678,"median":-0.772914,"eighty":-0.658692,"marketCap":49269057},{"date":"2025-10-03","current":-0.832828,"twenty":-1.3031,"median":-0.773415,"eighty":-0.659759,"marketCap":57819885},{"date":"2025-10-10","current":-0.85858,"twenty":-1.300684,"median":-0.778593,"eighty":-0.66033,"marketCap":59607803},{"date":"2025-10-17","current":-0.793893,"twenty":-1.298502,"median":-0.780043,"eighty":-0.660487,"marketCap":55116805},{"date":"2025-10-24","current":-0.758609,"twenty":-1.298107,"median":-0.781675,"eighty":-0.660809,"marketCap":52667169},{"date":"2025-10-31","current":-0.758609,"twenty":-1.295229,"median":-0.780043,"eighty":-0.661519,"marketCap":52667169},{"date":"2025-11-07","current":-0.699802,"twenty":-1.293394,"median":-0.777385,"eighty":-0.661519,"marketCap":48584442},{"date":"2025-11-14","current":-0.420798,"twenty":-1.292027,"median":-0.773415,"eighty":-0.659759,"marketCap":31929336},{"date":"2025-11-21","current":-0.374737,"twenty":-1.290995,"median":-0.772414,"eighty":-0.655493,"marketCap":28434257},{"date":"2025-11-28","current":-0.425103,"twenty":-1.289652,"median":-0.772414,"eighty":-0.653915,"marketCap":32255978},{"date":"2025-12-05","current":-0.387974,"twenty":-1.288426,"median":-0.772193,"eighty":-0.646972,"marketCap":29438684},{"date":"2025-12-12","current":-0.387651,"twenty":-1.286996,"median":-0.769847,"eighty":-0.645148,"marketCap":29414186},{"date":"2025-12-19","current":-0.39357,"twenty":-1.284376,"median":-0.767891,"eighty":-0.634528,"marketCap":29863320},{"date":"2025-12-26","current":-0.377481,"twenty":-1.281419,"median":-0.766254,"eighty":-0.630757,"marketCap":28642492},{"date":"2026-01-02","current":-0.376728,"twenty":-1.27871,"median":-0.766234,"eighty":-0.62474,"marketCap":28585330},{"date":"2026-01-09","current":-0.40783,"twenty":-1.278106,"median":-0.764809,"eighty":-0.617881,"marketCap":30945324},{"date":"2026-01-16","current":-0.392817,"twenty":-1.277097,"median":-0.760055,"eighty":-0.615402,"marketCap":29806157},{"date":"2026-01-23","current":-0.391741,"twenty":-1.273548,"median":-0.760055,"eighty":-0.612082,"marketCap":29724496},{"date":"2026-01-30","current":-0.388189,"twenty":-1.273044,"median":-0.758609,"eighty":-0.593654,"marketCap":29455016},{"date":"2026-02-06","current":-0.399597,"twenty":-1.271197,"median":-0.757769,"eighty":-0.575164,"marketCap":30320620}],"updateTime":1770698742566},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BRNS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2590385587","title":"Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2590385587","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590385587?lang=en_us&edition=fundamental","pubTime":"2025-12-10 21:00","pubTimestamp":1765371600,"startTime":"0","endTime":"0","summary":"VTP-1000, an antigen-specific immunotherapy to treat celiac disease, showed a dose-dependent pharmacological effect in the SAD portion of the trialVTP-1000 was well-tolerated with no treatment-related","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/10/3203120/0/en/Barinthus-Bio-Announces-Update-on-Phase-1-AVALON-Clinical-Trial-of-VTP-1000-for-the-Treatment-of-Celiac-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTP","BK4539","BRNS"],"gpt_icon":0},{"id":"2584236916","title":"Barinthus Biotherapeutics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2584236916","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584236916?lang=en_us&edition=fundamental","pubTime":"2025-11-17 20:39","pubTimestamp":1763383140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BRNS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 17, 2025 07:39 ET (12:39 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRNS","BK4139","BK4539"],"gpt_icon":0},{"id":"2581000427","title":"Barinthus Biotherapeutics Q3 EPS $(0.36) Beats $(0.45) Estimate, Sales $14.969M, Same YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2581000427","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581000427?lang=en_us&edition=fundamental","pubTime":"2025-11-07 20:41","pubTimestamp":1762519310,"startTime":"0","endTime":"0","summary":"Barinthus Biotherapeutics Q3 EPS $(0.36) Beats $(0.45) Estimate, Sales $14.969M, Same YoY","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48716523/barinthus-biotherapeutics-q3-eps-0-36-beats-0-45-estimate-sales-14-969m-same-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BRNS","BK4139"],"gpt_icon":0},{"id":"2581005130","title":"Press Release: Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2581005130","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581005130?lang=en_us&edition=fundamental","pubTime":"2025-11-07 20:30","pubTimestamp":1762518600,"startTime":"0","endTime":"0","summary":"-- Single ascending dose data readout for VTP-1000 expected before the end. -- Enrollment advancing in multiple ascending dose part of the AVALON trial;-- Proposed combination with Clywedog Therapeutics Inc.  to. strengthen and diversify the pipeline and broaden the Company's base of. GERMANTOWN, Md., Nov. 07, 2025  -- Barinthus Biotherapeutics plc  , an immunology and inflammation  company focused on developing therapies that promote immune tolerance with curative potential, today announced its financial results for the quarter ended September 30, 2025, and provided an overview of the Company's corporate developments.\"The proposed combination of Barinthus Bio and Clywedog represents an important step toward building a stronger, more resilient company, with several expected near-term catalysts.\" said Bill Enright, Chief Executive Officer of Barinthus Bio. \"By combining our complementary pipelines and deep expertise in metabolic and autoimmune diseases, we are diversifying risk across m","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BRNS","BK4139"],"gpt_icon":0},{"id":"2579938484","title":"Barinthus Biotherapeutics PLC  expected to post a loss of 45 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2579938484","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579938484?lang=en_us&edition=fundamental","pubTime":"2025-10-31 22:26","pubTimestamp":1761920767,"startTime":"0","endTime":"0","summary":"Barinthus Biotherapeutics PLC  expected to post a loss of45cents a share - Earnings Preview Barinthus Biotherapeutics PLC BRNS.OQ, BRNS.O is expected to  show a fall in quarterly revenue when it repor","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nL8N3WC1ME:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRNS","BK4539","BK4139"],"gpt_icon":0},{"id":"2577485285","title":"Press Release: ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2577485285","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577485285?lang=en_us&edition=fundamental","pubTime":"2025-10-24 23:00","pubTimestamp":1761318000,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Oct. 24, 2025 /PRNewswire/ -- ChemDiv, a global provider of integrated drug discovery solutions, today announced that it will continue providing chemistry, computational, and clinical pharmacology support to Clywedog Therapeutics as the company enters into a definitive merger agreement with Barinthus Therapeutics . The combined entity will operate under the name Clywedog Therapeutics, Inc. and is expected to list on Nasdaq under the ticker CLYD upon closing. The merged portfolio will focus on advancing clinical-stage candidates in Type 1 diabetes , Type 2 diabetes , and celiac disease.ChemDiv's ongoing collaboration includes accelerated CMC research, AI-enabled pharmacology, computational modeling, and translational biology, extending the successful transition of Clywedog's programs to the clinic in 2023--2024. ChemDiv's medicinal chemistry, in vitro and in vivo biology, and pharmacology services were instrumental in differentiating:. MEN PPI inhibitors -- first-in-class can","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","BRNS","LENZ","BK4539"],"gpt_icon":0},{"id":"2571342908","title":"Press Release: Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2571342908","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571342908?lang=en_us&edition=fundamental","pubTime":"2025-09-30 20:00","pubTimestamp":1759233600,"startTime":"0","endTime":"0","summary":"includes three differentiated, clinical stage product candidates which. -- Four key value-driving milestones are expected within 18 months,including clinical proof of concept in multiple indications. Estimated. cash runway for combined company extends through 2027.-- Transaction projected to close in the first half of 2026. The combined. company will be backed by OrbiMed and Torrey Pines and is expected to. Upon the closing of the transaction, the combined company will be renamed \"Clywedog Therapeutics, Inc.\" and is expected to trade on the NASDAQ under the new ticker symbol \"CLYD.\" The transaction is expected to close in the first half of 2026, with the combined company supported by existing cash and additional investments by OrbiMed and Torrey Pines Investment LLC, both existing shareholders in Clywedog, and new investors.Dr. Iain Dukes, a venture partner at OrbiMed who will serve as Executive Chairman of Clywedog Therapeutics after the transaction closes, commented, \"I am excited to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4139","BRNS","MNQmain","NVIW.SI","PSQ","TSYW.SI","USAW.SI","TQQQ",".IXIC","NQmain","QLD","SQQQ","BK4539","QID","USJW.SI","BK4007"],"gpt_icon":1},{"id":"2557986165","title":"Barinthus Biotherapeutics PLC reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2557986165","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557986165?lang=en_us&edition=fundamental","pubTime":"2025-08-08 01:32","pubTimestamp":1754587977,"startTime":"0","endTime":"0","summary":"Barinthus Biotherapeutics PLC reports results for the quarter ended June 30 - Earnings SummaryBarinthus Biotherapeutics PLC BRNS.OQ reported a quarterly adjusted loss of 52 cents per share for the qua","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nL8N3TZ2RV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRNS"],"gpt_icon":0},{"id":"2557456872","title":"Barinthus Biotherapeutics Q2 EPS $(0.52) Misses $(0.33) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557456872","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557456872?lang=en_us&edition=fundamental","pubTime":"2025-08-07 20:12","pubTimestamp":1754568776,"startTime":"0","endTime":"0","summary":"Barinthus Biotherapeutics (NASDAQ:BRNS) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.33) by 57.58 percent. This is a 20.93 percent decrease over losses of $(0.43) per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46959532/barinthus-biotherapeutics-q2-eps-0-52-misses-0-33-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRNS"],"gpt_icon":0},{"id":"2557565472","title":"Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2557565472","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557565472?lang=en_us&edition=fundamental","pubTime":"2025-08-07 20:00","pubTimestamp":1754568000,"startTime":"0","endTime":"0","summary":"The final cohort of the single ascending dose (SAD) part of the Phase 1 AVALON trial initiated, with the SAD data readout expected early in the fourth quarter of 2025;The multiple ascending dose (MAD)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/07/3129180/0/en/Barinthus-Bio-Reports-Second-Quarter-2025-Financial-Results-and-Updates-on-Corporate-Developments.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRNS","BK4539","BK4139"],"gpt_icon":0},{"id":"2556038732","title":"Barinthus Biotherapeutics PLC  expected to post a loss of 33 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2556038732","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556038732?lang=en_us&edition=fundamental","pubTime":"2025-08-04 21:54","pubTimestamp":1754315647,"startTime":"0","endTime":"0","summary":"Barinthus Biotherapeutics PLC  expected to post a loss of33cents a share - Earnings Preview Barinthus Biotherapeutics PLC BRNS.OQ, BRNS.O is expected to  show no change in quarterly revenue when it re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nL8N3TW1EK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRNS"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}]}}